Published in J Clin Hypertens (Greenwich) on January 01, 2006
Treatment of hypertension among African Americans: the Jackson Heart Study. J Clin Hypertens (Greenwich) (2013) 1.52
Whites have a more robust hypothalamic-pituitary-adrenal axis response to a psychological stressor than blacks. Psychoneuroendocrinology (2007) 1.00
Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hypertens (2011) 0.98
A 5-year longitudinal study of the relationships between stress, coping, and immune cell beta(2)-adrenergic receptor sensitivity. Psychiatry Res (2008) 0.93
Long QT syndrome in African-Americans. Ann Noninvasive Electrocardiol (2010) 0.84
Hypertensive target organ damage in Ghanaian civil servants with hypertension. PLoS One (2009) 0.84
Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study. Cardiovasc J Afr (2012) 0.82
Management of hypertension in the elderly patient at abidjan cardiology institute (ivory coast). Int J Hypertens (2011) 0.78
Echocardiographic pattern of acquired heart diseases in Nigeria. Niger Med J (2016) 0.75
Building on a Legacy of Hypertension Research: Charting Our Future Together. Hypertension (2016) 0.75
[Screening for cardiovascular disease among students at the University of Douala and influence of sport and physical activity]. Pan Afr Med J (2012) 0.75
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension (2016) 0.75
Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med (2005) 5.09
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol (2003) 2.47
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67
Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension (2004) 1.67
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy. Am J Geriatr Cardiol (2008) 1.48
A perspective on African American participation in clinical trials. Contemp Clin Trials (2006) 1.23
The Metabolic Syndrome in African Americans: a review. Ethn Dis (2003) 1.20
Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics. Ethn Dis (2011) 1.12
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study. Clin Trials (2013) 1.11
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens (Greenwich) (2005) 1.02
Reasons for discharges against medical advice: a qualitative study. Qual Saf Health Care (2010) 0.99
β-Adrenergic blockers. J Clin Hypertens (Greenwich) (2011) 0.96
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J Clin Hypertens (Greenwich) (2006) 0.94
The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens (Greenwich) (2011) 0.93
Readmissions after unauthorized discharges in the cardiovascular setting. Med Care (2011) 0.90
Addressing cardiovascular disparities through community interventions. Ethn Dis (2006) 0.89
Hypertension in black Americans as a special population: why so special? Curr Cardiol Rep (2006) 0.87
Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin. J Natl Med Assoc (2005) 0.87
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. J Natl Med Assoc (2006) 0.87
Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. Mayo Clin Proc (2008) 0.86
Treatment of heart failure in African Americans--a call to action. J Natl Med Assoc (2011) 0.85
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial. J Womens Health (Larchmt) (2008) 0.83
Social networks help control hypertension. J Clin Hypertens (Greenwich) (2012) 0.82
Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials. Clin Ther (2011) 0.81
Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich) (2015) 0.80
Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease. Ethn Dis (2009) 0.79
A qualitative evaluation of a citywide Community Health Partnership program. J Natl Med Assoc (2012) 0.78
Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus. J Clin Hypertens (Greenwich) (2009) 0.78
Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. Am J Hypertens (2003) 0.78
Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery. J Card Surg (2006) 0.77
The metabolic syndrome: recognition and management. Dis Manag (2006) 0.77
A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting. BMJ Open (2012) 0.75
Diabetes knowledge in a high risk urban population. Ethn Dis (2011) 0.75
For the patient. What is the Metabolic Syndrome and why is it important? Ethn Dis (2003) 0.75
Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores. Expert Rev Pharmacoecon Outcomes Res (2005) 0.75
Diabetes control through an educational intervention. Ethn Dis (2014) 0.75
Health care cost of analgesic use in hypertensive patients. Clin Ther (2004) 0.75